M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 4.71 EUR 4.67%
Market Cap: 75.9m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Intrinsic Value

MAAT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MAAT stock under the Base Case scenario is 19.42 EUR. Compared to the current market price of 4.71 EUR, Maat Pharma SA is Undervalued by 76%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAAT Intrinsic Value
19.42 EUR
Undervaluation 76%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case
Compare MAAT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MAAT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Maat Pharma SA

Provide an overview of the primary business activities
of Maat Pharma SA.

What unique competitive advantages
does Maat Pharma SA hold over its rivals?

What risks and challenges
does Maat Pharma SA face in the near future?

Has there been any significant insider trading activity
in Maat Pharma SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Maat Pharma SA.

Provide P/S
for Maat Pharma SA.

Provide P/E
for Maat Pharma SA.

Provide P/OCF
for Maat Pharma SA.

Provide P/FCFE
for Maat Pharma SA.

Provide P/B
for Maat Pharma SA.

Provide EV/S
for Maat Pharma SA.

Provide EV/GP
for Maat Pharma SA.

Provide EV/EBITDA
for Maat Pharma SA.

Provide EV/EBIT
for Maat Pharma SA.

Provide EV/OCF
for Maat Pharma SA.

Provide EV/FCFF
for Maat Pharma SA.

Provide EV/IC
for Maat Pharma SA.

Show me price targets
for Maat Pharma SA made by professional analysts.

What are the Revenue projections
for Maat Pharma SA?

How accurate were the past Revenue estimates
for Maat Pharma SA?

What are the Net Income projections
for Maat Pharma SA?

How accurate were the past Net Income estimates
for Maat Pharma SA?

What are the EPS projections
for Maat Pharma SA?

How accurate were the past EPS estimates
for Maat Pharma SA?

What are the EBIT projections
for Maat Pharma SA?

How accurate were the past EBIT estimates
for Maat Pharma SA?

Compare the revenue forecasts
for Maat Pharma SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Maat Pharma SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Maat Pharma SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Maat Pharma SA compared to its peers.

Compare the P/E ratios
of Maat Pharma SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Maat Pharma SA with its peers.

Analyze the financial leverage
of Maat Pharma SA compared to its main competitors.

Show all profitability ratios
for Maat Pharma SA.

Provide ROE
for Maat Pharma SA.

Provide ROA
for Maat Pharma SA.

Provide ROIC
for Maat Pharma SA.

Provide ROCE
for Maat Pharma SA.

Provide Gross Margin
for Maat Pharma SA.

Provide Operating Margin
for Maat Pharma SA.

Provide Net Margin
for Maat Pharma SA.

Provide FCF Margin
for Maat Pharma SA.

Show all solvency ratios
for Maat Pharma SA.

Provide D/E Ratio
for Maat Pharma SA.

Provide D/A Ratio
for Maat Pharma SA.

Provide Interest Coverage Ratio
for Maat Pharma SA.

Provide Altman Z-Score Ratio
for Maat Pharma SA.

Provide Quick Ratio
for Maat Pharma SA.

Provide Current Ratio
for Maat Pharma SA.

Provide Cash Ratio
for Maat Pharma SA.

What is the historical Revenue growth
over the last 5 years for Maat Pharma SA?

What is the historical Net Income growth
over the last 5 years for Maat Pharma SA?

What is the current Free Cash Flow
of Maat Pharma SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Maat Pharma SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Maat Pharma SA

Current Assets 27.6m
Cash & Short-Term Investments 20.2m
Receivables 6m
Other Current Assets 1.5m
Non-Current Assets 10.9m
Long-Term Investments 200k
PP&E 8.6m
Intangibles 1.8m
Other Non-Current Assets 286k
Current Liabilities 14.6m
Accounts Payable 8.8m
Accrued Liabilities 2.1m
Other Current Liabilities 3.7m
Non-Current Liabilities 13.6m
Long-Term Debt 12.8m
Other Non-Current Liabilities 774k
Efficiency

Free Cash Flow Analysis
Maat Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Maat Pharma SA

Revenue
3.2m EUR
Cost of Revenue
-1.3m EUR
Gross Profit
2m EUR
Operating Expenses
-30.4m EUR
Operating Income
-28.4m EUR
Other Expenses
-476k EUR
Net Income
-28.9m EUR
Fundamental Scores

MAAT Profitability Score
Profitability Due Diligence

Maat Pharma SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
24/100
Profitability
Score

Maat Pharma SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

MAAT Solvency Score
Solvency Due Diligence

Maat Pharma SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Average D/E
33/100
Solvency
Score

Maat Pharma SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 18.02 EUR with a low forecast of 15.66 EUR and a high forecast of 22.05 EUR.

Lowest
Price Target
15.66 EUR
232% Upside
Average
Price Target
18.02 EUR
283% Upside
Highest
Price Target
22.05 EUR
368% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Maat Pharma SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MAAT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MAAT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MAAT stock?

The intrinsic value of one MAAT stock under the Base Case scenario is 19.42 EUR.

Is MAAT stock undervalued or overvalued?

Compared to the current market price of 4.71 EUR, Maat Pharma SA is Undervalued by 76%.

Back to Top